Cml Biotech Limited - Due diligence report
A 360° intelligence report on Cml Biotech: trust score, financial health, credit view, compliance, directors, growth and distress signals - …
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Cml Biotech — 360° Intelligence Report
Generated from MCA filings & public recordsCml Biotech is assessed as Moderate with a Trust Score of 70/100. Cml Biotech is an active public limited indian non-government company incorporated in 1999, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.
Report generated on 22 Nov 2026 from the latest processed filings. Cml Biotech Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 0 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Negative operating earnings - debt service depends on external support.
- Open charges exceed net worth - secured lenders rank ahead.
- Elevated gearing (D/E 38%).
Charges position: 14 open ( 48.0 cr ) · 15 satisfied ( 12.5 cr ).
| Lender | Charges | Amount |
|---|---|---|
| Axis Bank Limited | 3 | 48.0 cr |
| Others | 5 | 48.0 cr |
| Sidbi | 10 | 48.0 cr |
| Hdfc Bank Limited | 1 | 48.0 cr |
| The South Indian Bank Limited | 7 | 48.0 cr |
| The Federal Bank Limited | 1 | 48.0 cr |
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2025).
- 4 active GST registration(s).
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| PARAPULLY VARKEY JOSHY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| JESSY POULOSE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ASHWIN PAUL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PAUL SHALINI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Ajayaghosh Ayyappan | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BHASKARANPILLAI SANTOSHKUMAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MR PAULOSE JACOB | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| POULOSE CHAKU | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 8 directors on the board.
- No disqualified or deactivated DINs.
- 3 director exit(s) in the last 3 years.
- Average tenure above 5 years.
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
Ownership & Group Intelligence
As per FY 2025 annual returnPromoters hold a dominant controlling stake - exact percentages are part of the full report.
Key managerial personnel: MR PAULOSE JACOB (Managing Director)
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 70 · Distress 60Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- 14 open charge(s) already registered.
- Compliance record supports lending.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 15 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Dhansri Steels Pvt Ltd | U27107AS1991PTC003606 | Tinsukia, Assam, India |
| Tech Plaastic | U25209TN1973PTC006392 | Sriperumbdur, Tamil Nadu, India |
| Montan Hydraulik (India) Private Limited | U30007TN1997PTC037810 | Ponneri, Tamil Nadu, India |
| Jayco Safety | U29270MH1997PTC108709 | Mumbai, Maharashtra, India |
| Velvin Packaging Solutions Private Limited | U21029MH2021PTC361289 | Mumbai, Maharashtra, India |
| Krriyan Kontainers Private Limited | U25202KA2010PTC053396 | Mysore, Karnataka, India |
| Karnawati Innovation Limited | L46200GJ1986PLC009009 | Daskroi, Gujarat, India |
| Indowud | U20299TN2018PTC122717 | Egmore Nungambakkam, Tamil Nadu, India |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Cml Biotech before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Cml Biotech: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Enhanced diligence advised. Credit risk score 20/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Mixed indicators. Growth score 70/100, margin trends, ownership structure and peer set for Cml Biotech - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 70/100, distress signals and MSME payment-delay disclosures - know whether Cml Biotech pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Cml Biotech - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Cml Biotech an active company?
Cml Biotech has MCA status “Active” with a compliance score of 88/100 (Low Risk).
Is Cml Biotech financially healthy?
Cml Biotech has a Financial Health Score of 25/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Cml Biotech?
Its overall Trust Score is 70/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Cml Biotech?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 8 active director(s) are on record.
Does Cml Biotech have loans or charges against its assets?
14 open charge(s) are registered against its assets, and 15 earlier charge(s) stand satisfied.
Is Cml Biotech up to date with its ROC filings?
Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).
Is it risky to lend to Cml Biotech?
Its Credit Risk Score is 20/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.